The invention relates to polycyclic aryl and heteroaryl substituted 4-pyrone
compounds useful as inhibitors of serine proteases of the coagulation cascade and
compounds, compositions and methods for anticoagulant therapy for the treatment
and prevention of a variety of thrombotic conditions including coronary artery
and cerebrovascular diseases.